Clinical Trials Sponsored by Institute for Medical Research, Inc.

Total 9776 results

Patton Medical Devices
Medstar Health Research Institute; Valeritas, Inc.

Completed

A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port

Type 1 Diabetes | Type 2 Diabetes

United States
Ludwig Institute for Cancer Research
Cancer Research Institute, NY, USA

Terminated

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Unresectable or Metastatic Melanoma

United States, Australia
D'Or Institute for Research and Education
Brazilian Clinical Research Institute

Unknown

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 (BRACE-CORONA)

COVID-19 | Corona Virus Infection

Brazil
McMaster University
McMaster Institute for Research in Aging; Canada Research Chair

Recruiting

The Effects of Exercise on Synaptic Plasticity in Individuals With Mild Cognitive Impairment and in Healthy Aging.

Mild Cognitive Impairment

Canada
Lundquist Institute for Biomedical Innovation at...
Emmaus Medical, Inc.

Terminated

L-Glutamine Therapy for Sickle Cell Anemia

Sickle Cell Anemia | Thalassemia

United States
Austin Institute for Clinical Research
SkinCeuticals

Not yet recruiting

Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

Photoaging

United States
D'Or Institute for Research and Education

Recruiting

Inspiratory Muscle Strength Training in Post-Covid Syndrome

Cardiovascular Abnormalities | Post-COVID-19 Syndrome | Physical Exercise

Brazil
Mario Negri Institute for Pharmacological Research

Recruiting

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)

Healthy | Autosomal Dominant Polycystic Kidney | Atypical Hemolytic Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients (REPRESS)

Hypertension
Mario Negri Institute for Pharmacological Research

Recruiting

B Cells in Idiopathic Nephrotic Syndrome (BLADE)

Nephrotic Syndrome

Italy
Austin Institute for Clinical Research
OrthoDermatologics

Recruiting

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

Plaque Psoriasis

United States
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study (GOETH)

Stomach Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)

Emergency Departments | Evaluation | Quality of Care | Appropriateness

Italy
Mario Negri Institute for Pharmacological Research

Completed

Thyroid Hormones in ADPKD (REORIENTED)

Autosomal Dominant Polycystic Kidney

Italy
Ludwig Institute for Cancer Research
AstraZeneca

Completed

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Esophageal Cancer

United Kingdom
Mario Negri Institute for Pharmacological Research

Withdrawn

COVID-19 Algorithm Treatment at Home (COVER-HOME)

COVID-19
Mario Negri Institute for Pharmacological Research

Terminated

Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance (MSC-KTX)

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Genetic Study of Nephrolithiasis in Gouty Diathesis

Nephrolithiasis

Italy
Mario Negri Institute for Pharmacological Research

Completed

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Alport Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Prevent Hospitalization for COVID-19 Patients (COVER2)

Covid19

Italy
Palo Alto Veterans Institute for Research

Completed

Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy

Written Exposure Therapy | Imaginal Exposure Therapy

United States
Mario Negri Institute for Pharmacological Research

Completed

COVID-19 Impact on the Lombardy Region's Emergency System

Covid19

Italy
D'Or Institute for Research and Education

Enrolling by invitation

Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals

Sepsis

Brazil
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Remission Clinic in Proteinuric Chronic Nephropathies

Chronic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Treat COVID-19 Patients at Home. (COVER)

COVID 19

Italy
D'Or Institute for Research and Education

Withdrawn

Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia

COVID-19

Brazil
Palo Alto Veterans Institute for Research

Completed

Testing a Self-Management App for Symptoms of Posttraumatic Stress

PTSD

United States
Mario Negri Institute for Pharmacological Research

Completed

Decision-aid on Breast Cancer Screening

Breast Cancer

Italy
Nathan Kline Institute for Psychiatric Research

Completed

D-serine and Cognitive Remediation in Schizophrenia

Schizophrenia

United States
D'Or Institute for Research and Education

Unknown

CORE Study COVID-19

Coronavirus Infection (COVID-19)

Brazil
Mario Negri Institute for Pharmacological Research

Terminated

Insulin Treatment in Diabetic Older People With Heart Failure. (Insulin-HF)

Heart Failure | Diabetes Mellitus, Type 2

Italy
Mario Negri Institute for Pharmacological Research

Completed

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma (Ortataxel)

Glioblastoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF (SIM-AF)

Atrial Fibrillation | Elderly | Geriatrics | Simulation Training | Anticoagulant Drugs | Internal Medicine | Drug Prescriptions

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) (ORCHIDEE)

Renal Cell Carcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

Autosomal Dominant Polycystic Kidney Disease

Italy
Nathan Kline Institute for Psychiatric Research

Completed

Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic (TDCSSCHIZ)

Schizophrenia | Cognition | Cigarette Smoking

United States
Palo Alto Veterans Institute for Research

Completed

Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance

Age-related Cognitive Decline

United States
Mario Negri Institute for Pharmacological Research

Completed

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain (RER)

Neuropathic Pain | Tumor | Cancer Pain | Breakthrough Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Completed

RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. (CERP)

Cancer | Cancer Pain

Italy
D'Or Institute for Research and Education

Completed

Blame Rebalance fMRI Feedback Proof-of-concept (GUIMRINFB1)

Major Depressive Disorder

Brazil
Mario Negri Institute for Pharmacological Research

Completed

Multicentric Observational Study on Quality of Life in Glaucoma

Primary Open-angle Glaucoma

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Type 2 Diabetes | Early Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Completed

Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma (GILDA)

Colorectal Cancer | Surveillance
Mario Negri Institute for Pharmacological Research

Completed

Telmisartan Versus Losartan in Kidney Transplantation (COSTANT)

Renal Transplant

Italy
Rhine-Westphalia Institute for Economic Research

Unknown

Obesity and Financial Incentives (Obesity)

Obesity

Germany
Mario Negri Institute for Pharmacological Research

Completed

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

Cardiovascular Diseases

Italy
Mario Negri Institute for Pharmacological Research

Completed

Acetylcarnitine and Insulin Sensitivity

Type 2 Diabetes Mellitus

Italy
Mario Negri Institute for Pharmacological Research

Completed

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Kidney Transplant

Italy
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh; Kenya Medical...

Completed

Impact of Home Zinc Treatment for Acute Diarrhea in Children

Diarrhea

Kenya
University of Nottingham
Michael J. Fox Foundation for Parkinson's Research; National Institute for...

Unknown

Nigrosomal Iron Imaging in Parkinson's Disease (N3iPD)

Parkinson Disease

United Kingdom

Clinical Trials Sponsored by Institute for Medical Research, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations